- Home
- HUBG vs SLNO Comparison
HUBG vs SLNO Comparison
Compare HUBG & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUBG | SLNO |
|---|---|---|
| Founded | 1971 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.3B |
| IPO Year | 1996 | 2014 |
Fundamental Metrics
Financial Performance| Metric | HUBG | SLNO |
|---|---|---|
| Price | $34.27 | $33.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $45.33 | ★ $108.00 |
| AVG Volume (30 Days) | 731.0K | ★ 1.4M |
| Earning Date | 05-07-2026 | 05-29-2026 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | N/A | ★ 108.90 |
| EPS | ★ 1.34 | 0.39 |
| Revenue | ★ $3,946,390,000.00 | $1,450,788.00 |
| Revenue This Year | N/A | $155.44 |
| Revenue Next Year | $2.77 | $57.99 |
| P/E Ratio | ★ $25.19 | $87.46 |
| Revenue Growth | N/A | ★ 138.82 |
| 52 Week Low | $30.75 | $32.63 |
| 52 Week High | $53.26 | $89.12 |
Technical Indicators
Market Signals| Indicator | HUBG | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 25.23 | 32.35 |
| Support Level | $32.43 | $32.63 |
| Resistance Level | $36.74 | $41.48 |
| Average True Range (ATR) | 1.66 | 2.36 |
| MACD | -0.69 | -0.47 |
| Stochastic Oscillator | 7.01 | 9.86 |
Price Performance
Historical ComparisonAbout HUBG Hub Group Inc.
Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset-light truck brokerage operations along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub often makes tuck-in acquisitions that expand its brokerage, last-mile, and dedicated offerings.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.